Speaking on her YouTube channel, Kathy explained: "They made me an offer and the offer was for $1.4 [million] and I am just going to be honest, I had to turn it down because at th ...

Kathy Griffin once rejected a $1.4 million offer to join The View. The 64-year-old comedy star has revealed that she was ...

After the game, Robert Griffin III didn’t hold back his praise for the superstar: “Caitlin Clark is the greatest women’s 3-point shooter ever, and it’s only her 2nd year in the WNBA.” ...

Comedian Kathy Griffin and former CNN anchor Don Lemon agreed that the 2024 presidential election could have been rigged in favor of President Donald Trump.

Comedian Kathy Griffin and former CNN anchor Don Lemon agreed that the 2024 presidential election could have been rigged in favor of President Donald Trump.

Comedian Kathy Griffin and former CNN anchor Don Lemon agreed that the 2024 presidential election could have been rigged in favor of President Donald Trump. Read More. Related Posts. California Lt.

Don Lemon said he wouldn’t dispute Kathy Griffin’s claim that Trump and Elon Musk rigged the 2024 election, agreeing that "something was off." Skip to main content Manage Subscription Sign in !

Doctors at the University of Louisville’s Brown Cancer Center have found that a new cancer treatment is showing promising results. “I have been living with Stage IV lung cancer for 6 years,” Margie ...

Paramount Global chair Shari Redstone was diagnosed with thyroid cancer earlier this spring, a spokesperson for Redstone said in a statement to Reuters on Thursday.

Hedge fund titan Ken Griffin ramped up his war of words with the Trump White House on Wednesday, blasting the president's so-called 'Big, Beautiful' tax bill for adding to Uncle Sam's eye-popping ...

Former White House aide and current political pundit Alyssa Farah Griffin said tech billionaire Elon Musk has the power to derail President Trump’s domestic agenda with his threats to primary ...

References: Rudin C, Mountzios G, Sun L, et al. Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304.ASCO 2025 ...